FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3905380 · Received July 1, 2014

Report

Report Number
2124215-2014-10847
Event Type
Injury
Date Received
July 1, 2014
Date of Event
May 6, 2014
Report Date
May 6, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) LEAD EXHIBITED HIGH OUT OF RANGE PACE IMPEDANCE MEASUREMENTS. IMPEDANCE MEASUREMENTS WERE NOTED TO HAVE INCREASED OVER THE COURSE OF APPROXIMATELY ONE YEAR PRIOR TO GOING OUT OF RANGE. THERE WAS A SLIGHT INCREASE IN RV PACING THRESHOLD. SENSING WAS STABLE AND NO EPISODES OF NOISE WERE RECORDED TO THE DEVICE. A REVISION PROCEDURE WAS PERFORMED WHEREIN BOTH THE DEVICE AND LEAD WERE REPLACED WITH THE ICD BEING EXPLANTED AND RV LEAD SURGICALLY ABANDONED. MEASUREMENTS ON THE NEW SYSTEM WITH WITHIN NORMAL LIMITS. THE PATIENT WAS REPORTED TO NOT BE PACEMAKER DEPENDENT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. THIS ICD AND RV LEAD ARE NO LONGER IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
382319 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F102

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R F102| 0292| F140| 0175